INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Observational study / 2005

Yersinia enterocolitica O:3 infection was linked to a higher prevalence of inflammatory bowel disease.

Between 1990 and 1997, antibody responses against Y. enterocolitica were evaluated in 1588 patients by tube agglutination. Forty-one patients with infection (titer = 320) and 1041 controls without antibody response were followed for 6-13 years until 2003. Overall, IBD occurred in 8 of 41 patients in the infection group (5 with ulcerative colitis, 3 with Crohn's disease) compared to 42 of 1041 in the control group (32 UC, 10 CD), representing a statistically significant difference (p = 0.00035). Significant differences were also found when examining ulcerative colitis (p = 0.006) and Crohn's disease (p < 0.015) separately.

Shows an association, not proof of cause and effect.

Study type
Cohort study
Who was studied
41 patients with Y. enterocolitica infection and 1041 controls without antibody response
What was measured
Prevalence of inflammatory bowel disease (ulcerative colitis and Crohn's disease) over 6-13 years

THE PAPER

Inflammatory bowel disease associated with Yersinia enterocolitica O:3 infection.

Saebo A, Vik E, Lange OJ, Matuszkiewicz L. Eur J Intern Med, 2005.

PubMed 15967332 ↗DOI 10.1016/j.ejim.2004.11.008 ↗

Gut & microbiomeFood safety & contaminants

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.